DELRAY BEACH, Fla., Aug. 2, 2010 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or the "Company") (Nasdaq:PSID) announced today that Mary Ellen Harrison has joined the Company as Vice President of Marketing and Business Development. Harrison will be responsible for developing the overall go-to-market strategies, including forging partnerships and distribution relationships, for the Company's HealthID development products.
Harrison has more than 15 years of business development experience and previously led business development efforts at Sensei Inc., a mobile and web-based wellness solutions provider formed by Humana Inc. Prior to Sensei, Harrison served as the Global Head of Marketing and International Account Management of a $1 billion business unit within Tyco Inc., where she headed marketing and led a global team responsible for marketing, strategic planning and sales. She also served as executive vice president for global strategy and business development for a joint venture company funded by Oracle Corporation and Alcatel. She currently serves on the Advisory Board for Arizona State University's School of Biological and Health Systems Engineering and has held senior marketing, sales and strategy roles with global leaders such as AT&T Inc., NCR Corporation and Bank of America Corporation.
Harrison will initially focus her efforts on developing a marketing strategy and partnership opportunities for the Company's iGlucose system, a stand-alone, self-contained unit that automatically queries a diabetic user's data-capable glucometer for blood glucose data and sends that data via encrypted SMS text messaging to an online database. The Company expects to submit its 510(k) for the iGlucose system in 2010.
Scott R. Silverman, Chairman and CEO of PositiveID, said, "We are excited to have Mary Ellen join our team at this important time for our Company as we develop our marketing strategy and launch plans for our iGlucose system and other diabetes management products under development. We believe that Mary Ellen's expertise and proven track record of building successful relationships and products will be leveraged to benefit our Company, our stakeholders and those affected by diabetes."
Harrison earned a master's degree from Thunderbird, The American Graduate School of International Management, and also received a bachelor's degree in finance from the University of Florida.
About PositiveID Corporation
PositiveID Corporation develops and markets healthcare and information management products through its RFID-based diagnostic devices and identification technologies, and its proprietary disease management tools. PositiveID operates in two main divisions: HealthID and ID Security. For more information on PositiveID, please visit www.PositiveIDCorp.com.
The PositiveID Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7717
Statements about PositiveID's future expectations, including the ability of the Company to launch its iGlucose system and future HealthID products, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID's actual results could differ materially from expected results. These risks and uncertainties include the Company's ability to successfully develop, fund and commercialize the iGlucose system, as well as certain other risks. Additional information about these and other factors that could affect the Company's business is set forth in the Company's various filings with the Securities and Exchange Commission, including those set forth in the Company's 10-K filed on March 19, 2010, and the Company's 10-Q filed on May 6, 2010, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.